Compounds > morpholinoanthracycline mx2
Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Breast Neoplasms

morpholinoanthracycline mx2 has been researched along with Breast Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, O; Adachi, I; Enomoto, K; Haga, S; Kawamura, E; Kimura, K; Kusama, M; Narabayashi, M; Watanabe, T; Yamada, Y1
Abe, O; Adachi, I; Enomoto, K; Kajiwara, T; Katsumata, N; Kusama, M; Ogawa, M; Tominaga, T; Watanabe, T; Yamada, Y1
Majima, H; Shinkai, H1
Abe, O; Asanuma, F; Ishibiki, K; Josui, K; Kawamura, E; Koh, J; Kubota, T; Shiina, E; Suto, A; Yamada, Y1
Majima, H1
Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Mizunuma, N; Mukaiyama, T; Nagamine, D; Ogawa, M; Shinagawa, K; Tabata, M1

Trials

2 trial(s) available for morpholinoanthracycline mx2 and Breast Neoplasms

ArticleYear
MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in refractory metastatic breast cancer: results of a preliminary phase II trial.
    Japanese journal of clinical oncology, 1993, Volume: 23, Issue:4

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Female; Humans; Middle Aged

1993
Phase II study of KRN8602, 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin hydrochloride, MX2 x HCl in patients with metastatic breast cancer.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Metastasis

1999

Other Studies

4 other study(ies) available for morpholinoanthracycline mx2 and Breast Neoplasms

ArticleYear
[Pharmacokinetics of KRN 8602 in cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:15

    Topics: Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged

1991
Antitumor activity and pharmacokinetics of a morpholino-anthracycline derivative (KRN8602) against human breast carcinoma xenografts serially transplanted into nude mice.
    Japanese journal of cancer research : Gann, 1990, Volume: 81, Issue:8

    Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Specific Pathogen-Free Organisms

1990
[Phase I clinical study of MX2 (KRN 8602)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:3 Pt 1

    Topics: Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Vomiting

1990
[Phase I and pharmacokinetic study of KRN8602, a new morpholino anthracycline].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:7

    Topics: Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carubicin; Drug Evaluation; Female; Hodgkin Disease; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia

1989